Patterns of recurrence and survival after surgery or stereotactic radiotherapy for early stage NSCLC

Journal of Thoracic Oncology

Volumn 10, Issue 5, 2015, Pages 826-831

  Van Den Berg, Liseth L ^a   Klinkenberg, Theo J ^a   Groen, Harry J M ^a   Widder, Joachim ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Early stage NSCLC; Lobectomy; Non small cell lung cancer; Stereotactic radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DISTANT METASTASIS; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STEREOTACTIC ABLATIVE RADIOTHERAPY; TUMOR RECURRENCE; VERY ELDERLY; WORLD HEALTH ORGANIZATION; CARCINOMA, NON-SMALL-CELL LUNG; COMPARATIVE STUDY; HEALTH STATUS; LUNG NEOPLASMS; LUNG RESECTION; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PATIENT SELECTION; RADIOGRAPHY; RADIOSURGERY; RETROSPECTIVE STUDY; SCINTISCANNING; SECONDARY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HEALTH STATUS; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT SELECTION; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; RADIOSURGERY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84938289605     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000483     Document Type: Article

References (28)

1. Goldstraw P, Crowley J, Chansky K, International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007 2 706 714
2. Darling GE, Allen MS, Decker PA, Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg 2011 141 662 670
3. Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman BJ, Senan S, Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: A population-based time-trend analysis. J Clin Oncol 2010 28 5153 5159
4. Bach PB, Cramer LD, Warren JL, Begg CB, Racial differences in the treatment of early-stage lung cancer. N Engl J Med 1999 341 1198 1205
5. Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM, Natural history of stage I non-small cell lung cancer: Implications for early detection. Chest 2007 132 193 199
6. Gauden S, Ramsay J, Tripcony L, The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest 1995 108 1278 1282
7. Lagerwaard FJ, Senan S, van Meerbeeck JP, Graveland WJ, Rotterdam Oncological Thoracic Study Group Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for stage I non-small cell lung cancer? Radiother Oncol 2002 63 151 157
8. Widder J, Postmus D, Ubbels JF, Wiegman EM, Langendijk JA, Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer. Int J Radiat Oncol Biol Phys 2011 81 e291 e297
9. Soldà F, Lodge M, Ashley S, Whitington A, Goldstraw P, Brada M, Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort. Radiother Oncol 2013 109 1 7
10. Crabtree TD, Puri V, Robinson C, Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy. J Thorac Cardiovasc Surg 2014 147 1183 1191; discussion 1191
11. Verstegen NE, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S, Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: Comparison with a contemporaneous cohort with pathologically proven disease. Radiother Oncol 2011 101 250 254
12. Baumann P, Nyman J, Hoyer M, Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009 27 3290 3296
13. Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2012 83 348 353
14. Grills IS, Mangona VS, Welsh R, Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 2010 28 928 935
15. Crabtree TD, Denlinger CE, Meyers BF, Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2010 140 377 386
16. Verstegen NE, Oosterhuis JW, Palma DA, Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): Outcomes of a propensity score-matched analysis. Ann Oncol 2013 24 1543 1548
17. Robinson CG, DeWees TA, El Naqa IM, Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer. J Thorac Oncol 2013 8 192 201
18. Goyal K, Einstein D, Yao M, Cyberknife stereotactic body radiation therapy for nonresectable tumors of the liver: preliminary results. HPB Surg 2010. http://dx.doi.org/10.1155/2010/309780
19. Vansteenkiste J, De Ruysscher D, Eberhardt WE, Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013 24 vi89 vi98
20. rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013 143 e278S e313S
21. Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S, Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: A retrospective analysis. Lancet Oncol 2012 13 802 809
22. Varlotto J, Fakiris A, Flickinger J, Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery. Cancer 2013 119 2683 2691
23. Timmerman R, Paulus R, Galvin J, Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010 303 1070 1076
24. Onishi H, Shirato H, Nagata Y, Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: Can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 2011 81 1352 1358
25. Robson JM, Vaidyanathan S, Cheyne L, Snee M, Franks K, Callister ME, Occult nodal disease in patients with non-small-cell lung cancer who are suitable for stereotactic ablative body radiation. Clin Lung Cancer 2014 15 466 469
26. Licht PB, Jorgensen OD, Ladegaard L, A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer. Ann Thorac Surg 2013 96 943 949; discussion 949 950
27. Lu P, Sun Y, Sun Y, Yu L, The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma. Lung Cancer 2014 85 53 58
28. Li L, Ren S, Zhang Y, Risk factors for predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients staged by PET/CT: Potential value in the clinic. Lung Cancer 2013 81 213 217